Case-Based Learning: Interpreting Discordant Clinical Findings in a Patient With Multisystem Symptoms

Abstract

Patients presenting with multisystem symptoms often challenge clinicians due to discordant clinical findings that may obscure the underlying diagnosis. Case-based learning (CBL) offers a structured, interactive approach to deepen understanding of such complex presentations and enhances diagnostic acumen. This review synthesizes current evidence on integrating CBL into medical practice to interpret conflicting clinical data, focusing on mechanisms, risk factors, and practical management strategies. Recent advances, guideline recommendations, and the educational value of CBL are discussed to provide an academically robust framework for healthcare professionals.

Introduction

Multisystem presentations are increasingly encountered in modern clinical practice, often manifesting as a constellation of symptoms that span multiple organ systems. These cases frequently involve discordant or seemingly contradictory clinical findings, posing significant diagnostic and therapeutic challenges. Case-based learning, rooted in adult learning theory, leverages real or simulated clinical scenarios to foster critical thinking and contextual application of knowledge. This article explores the pivotal role of CBL in enhancing clinicians ability to synthesize discordant findings and optimize patient outcomes, drawing on recent literature and expert consensus.

Epidemiology / Disease Burden

Multisystem diseases, such as systemic autoimmune disorders, infectious syndromes, and metabolic conditions, account for a substantial proportion of complex medical admissions worldwide. Epidemiological data highlight that up to 20% of internal medicine inpatients exhibit symptoms affecting two or more organ systems. Discordant findings defined as clinical signs or laboratory results that do not conform to a single diagnostic entity are prevalent in diseases such as systemic lupus erythematosus (SLE), sarcoidosis, and paraneoplastic syndromes. The rising incidence of such cases is attributed to aging populations, increased diagnostic testing, and improved recognition of atypical presentations. The burden on healthcare systems is significant, with prolonged hospital stays, increased diagnostic work-up, and greater risk of misdiagnosis.

Pathophysiology

The pathophysiological basis for discordant clinical findings in multisystem disease is multifactorial. Immune dysregulation, genetic predisposition, and environmental triggers can result in overlapping or sequential organ involvement. For example, autoantibody-mediated damage in SLE can simultaneously affect the kidneys, skin, and central nervous system, each presenting with unique clinical and laboratory profiles. Similarly, infectious agents such as HIV or tuberculosis may cause multi-organ pathology with variable manifestations due to host-pathogen interactions. The coexistence of comorbidities further complicates interpretation, as drug side effects or secondary phenomena (e.g., paraneoplastic syndromes) may mimic or mask primary disease processes.

Risk Factors

Risk factors for developing multisystem disease with discordant findings include genetic susceptibility (e.g., HLA-DR alleles in autoimmune diseases), environmental exposures (toxins, infections), and demographic factors such as age, sex, and ethnicity. Polypharmacy in elderly patients increases the likelihood of atypical presentations via drug interactions or adverse effects. Immunosuppression, whether due to underlying disease or therapy, predisposes to opportunistic infections that can further confound the clinical picture. Social determinants of health, including limited access to care and low health literacy, may delay diagnosis and contribute to diagnostic complexity.

Clinical Features

Patients with multisystem involvement present with a wide spectrum of symptoms, often with fluctuating severity and temporal patterns. Common features include constitutional symptoms (fever, weight loss, fatigue), cutaneous manifestations, polyarthritis, neurological deficits, and cardiorespiratory compromise. Discordant findings may manifest as laboratory-clinical mismatches (e.g., nephrotic-range proteinuria in the absence of edema), incongruent imaging results, or atypical response to standard therapies. Careful history-taking and serial examination are essential to detect evolving patterns and subtle clues. CBL emphasizes the iterative process of hypothesis generation and testing, refining diagnostic reasoning through feedback and reflection.

Diagnosis

Diagnostic evaluation requires a systematic approach integrating clinical, laboratory, and imaging data. Initial broad differential diagnosis should be narrowed by identifying red flags, temporal relationships, and patterns of organ involvement. Laboratory investigations may include autoantibody panels, infectious serologies, metabolic screens, and tissue biopsies. Advanced imaging modalities (MRI, PET-CT) and functional tests (pulmonary function, echocardiography) can elucidate organ-specific involvement. Multidisciplinary collaboration is often necessary, particularly when findings are discordant or non-specific. CBL sessions can simulate real-world complexity, allowing clinicians to practice diagnostic prioritization and error recognition in a safe environment.

Treatment & Management

Management strategies must be tailored to the underlying etiology and the specific organ systems involved. Empirical therapy may be warranted in life-threatening situations (e.g., high-dose corticosteroids in suspected vasculitis) while awaiting definitive diagnosis. Treatment regimens often involve immunosuppressants, biologics, antimicrobials, or supportive interventions. Close monitoring for drug toxicity and secondary complications is essential, especially when findings are discordant and the response to therapy is unpredictable. Patient-centered care, with clear communication regarding diagnostic uncertainty, is critical to maintaining trust and adherence. Case-based discussions facilitate the translation of evidence-based guidelines to individualized patient scenarios, highlighting pitfalls and best practices.

Recent Advances / Emerging Therapies

Recent advances in genomics, proteomics, and immunophenotyping are transforming the diagnosis and management of multisystem diseases. Next-generation sequencing allows identification of rare genetic syndromes presenting with discordant findings, while multiplex assays enable comprehensive autoantibody profiling. Targeted therapies, such as JAK inhibitors and monoclonal antibodies, offer new options for refractory cases but require careful patient selection and monitoring. Artificial intelligence (AI) and machine learning algorithms are being developed to aid pattern recognition in complex cases, though clinical validation remains ongoing. CBL platforms increasingly incorporate digital simulations and virtual patients, enhancing experiential learning and reflective practice.

Guideline Recommendations

International guidelines, including those from the American College of Rheumatology and the European League Against Rheumatism, emphasize a structured, multidisciplinary approach to multisystem disease. Key recommendations include early referral to specialty care, routine use of standardized assessment tools, and shared decision-making. For educational settings, consensus supports the integration of CBL into residency and continuing professional development curricula, citing improved diagnostic accuracy and team communication. Guideline adaptation to local resources and patient populations is advocated, with ongoing evaluation of implementation outcomes.

Conclusion

Interpreting discordant clinical findings in patients with multisystem symptoms demands advanced clinical reasoning, multidisciplinary collaboration, and ongoing education. Case-based learning provides a robust framework for developing these competencies, bridging the gap between theory and practice. Recent scientific advances and evolving guidelines continue to enhance our ability to diagnose and manage complex cases, ultimately improving patient care and outcomes. Ongoing research and innovation in medical education will further strengthen clinicians capacity to navigate diagnostic uncertainty with confidence and precision.